AbbVie (NYSE: ABBV), today announced that nine (9) provinces have provided accelerated public coverage of EPKINLY™. EPKINLY is a treatment for adult patients with Relapsed or Refractory diffuse large ...
AbbVie (NYSE: ABBV) today announced that nine provinces have provided accelerated public coverage of EPKINLY™. EPKINLY is a treatment for adult patients with Relapsed or Refractory diffuse large ...
Micrograph of a diffuse large B cell lymphoma, AbbVie and partner Genmab have FDA approval for the lead drug in their $3.9 billion cancer partnership, with bispecific antibody Epkinly now cleared ...
Access to high-quality education is a human right that not only greatly benefits individuals but also uplifts entire communities. Millions of children, however, remain out of school due to a variety ...
In that indication, the drug competes with AbbVie and Genmab’s rival CD20xCD3 bispecific Epkinly (epcoritamab), so moving it into the first relapse setting could hand Roche an advantage.
JSC did not participate in High Court case brought by liquidators of GTLK Europe DAC and GTLK Europe Capital DAC in case relating to 37 aircraft worth over €1.85bn ...
McDonald's is facing lawsuits from two individuals who contracted E. coli linked to slivered onions in their Quarter Pounder burgers. The outbreak has affected 49 people across 10 states ...